Helen of Troy Limited (HELE) Cash Flow Statement

The most consequential signal in Helen of Troy's cash flow profile is the extraordinary disconnect between reported net income and operating cash flow during the 2026 impairment quarters. In 2026Q1, the company reported -$450.7M in net income yet generated $58.3M in operating cash flow — an OCF/NI ratio that would be mathematically impossible without substantial non-cash addbacks, most likely goodwill or intangible asset write-downs consistent with the previously identified impairment pattern. By 2027Q1 and 2027Q2, net income returned to positive territory ($35.8M and $4.6M respectively), confirming that the 2026 losses were not operational in nature. However, the conversion quality in the most recent quarters remains mixed: 2027Q1 produced positive net income of $35.8M with essentially zero operating cash flow (OCF of -$636K), suggesting working capital absorption consumed essentially all reported earnings that period. The 2027Q2 rebound to $57.1M OCF on just $4.6M net income (12.3x conversion) may partly reflect a $10.7M working capital release rather than an improvement in cash earnings quality, a distinction investors should not overlook.

The free cash flow trajectory for Helen of Troy is best characterized as functional but unpredictable on a quarterly basis. The negative FCF margin of -1.6% in 2027Q1 contrasts sharply with +16.7% in 2026Q4, a pattern driven primarily by the $76.1M working capital release in Q4 followed by a $10.7M working capital absorption in Q1 — a classic seasonal restocking cycle for a consumer products company heading into the holiday quarter. On a trailing four-quarter basis (2026Q3 through 2027Q2), cumulative FCF of approximately $140.6M on roughly $1.79B in TTM revenue implies an annualized FCF margin near 7.9%, which is respectable relative to consumer peers like Newell Brands (1.6%) and ACCO (3.3%), though still meaningfully below Church & Dwight's 17.9%. The concern is not the absolute level but the consistency: only three of the last four quarters show FCF above $5M, and the 2027Q1 near-zero result raises questions about whether reported profitability is translating predictably into cash, particularly amid the SG&A expansion flagged in prior income statement analysis.

The low and relatively stable capex profile — ranging from 1.0% to 3.6% of revenue in eight of the last ten quarters — is consistent with the company's reliance on third-party contract manufacturers in Asia rather than owned production facilities. The 2026Q4 outlier of $33.1M (7.0% of revenue) represents a material deviation from this pattern and warrants investigation; it may relate to an investment in distribution infrastructure or technology systems following the Osprey acquisition, though the data alone does not confirm the driver. D&A of $12.8M to $14.2M per quarter remains remarkably stable, indicating the existing asset base is not being significantly expanded or contracted. With capex running at roughly $5-6M in the most recent quarter (2027Q2: $5.8M at 1.3% of revenue) against D&A of $13.0M, the company is currently investing well below replacement levels — a pattern that may be sustainable in the near term under an asset-light model but could signal deferred investment in logistics or technology capabilities if prolonged.

The capital deployment pattern reveals a company that has effectively halted direct shareholder distributions. Across all ten quarters, cumulative dividends paid were zero, a decision that may reflect balance sheet preservation following the Osprey acquisition and the erosion of equity from impairment charges rather than a strategic pivot per se. The $103.0M buyback in 2025Q1 represents the only meaningful repurchase activity, and the trickle of buybacks thereafter (averaging under $500K per quarter) suggests management views current share prices as unpersuasive or, more likely, prioritizes liquidity. The $78.2M appearing as a positive acquisition inflow in 2027Q1, exactly offset by a -$78.2M outflow in 2027Q2, is unusual and may represent a divestiture or contingent consideration adjustment rather than a net-new deal — investors should monitor subsequent 10-Q filings for clarification. Given the strained equity position and elevated leverage flagged in prior analysis, the suspension of dividends appears financially prudent but may further pressure the stock's appeal among income-oriented investors.